Article
Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
Surgery - 1 Jan 2021
Pieterman Carolina R C, Hyde Samuel M, Wu Si-Yuan, Landry Jace P, Chiang Yi-Ju, Christakis Ioannis, Grubbs Elizabeth G, Fisher Sarah B, Graham Paul H, Waguespack Steven G, Perrier Nancy D
Abstract excerpt
BACKGROUND: It is unclear whether genotype-negative clinical multiple endocrine neoplasia type 1 patients derive equal benefit from prospective surveillance as genotype-positive patients. METHODS: In this retrospective cohort study, we compared genotype-negative patients with clinical multiple endocrine neoplasia type 1 with genotype-positive index cases. Primary outcome was age-related penetrance of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
